Michael Sarcone
Stock Analyst at Jefferies
(0.16)
# 4,902
Out of 5,182 analysts
10
Total ratings
25%
Success rate
-23.06%
Average return
Main Sectors:
Stocks Rated by Michael Sarcone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Maintains: Hold | $81 → $66 | $55.11 | +19.76% | 2 | Feb 12, 2026 | |
| AXGN Axogen | Maintains: Buy | $29 → $36 | $41.99 | -14.27% | 2 | Dec 4, 2025 | |
| ALGN Align Technology | Downgrades: Hold | $215 → $140 | $177.28 | -21.03% | 1 | Oct 10, 2025 | |
| EDAP EDAP TMS | Downgrades: Hold | $8 → $2 | $3.28 | -39.02% | 2 | Apr 4, 2025 | |
| PRCT PROCEPT BioRobotics | Initiates: Hold | $95 | $23.03 | +312.51% | 1 | Nov 14, 2024 | |
| GKOS Glaukos | Upgrades: Buy | $84 → $125 | $119.63 | +4.49% | 1 | May 6, 2024 | |
| PROF Profound Medical | Downgrades: Equal-Weight | $5.5 → $10 | $6.69 | +49.48% | 1 | Mar 21, 2023 |
Inspire Medical Systems
Feb 12, 2026
Maintains: Hold
Price Target: $81 → $66
Current: $55.11
Upside: +19.76%
Axogen
Dec 4, 2025
Maintains: Buy
Price Target: $29 → $36
Current: $41.99
Upside: -14.27%
Align Technology
Oct 10, 2025
Downgrades: Hold
Price Target: $215 → $140
Current: $177.28
Upside: -21.03%
EDAP TMS
Apr 4, 2025
Downgrades: Hold
Price Target: $8 → $2
Current: $3.28
Upside: -39.02%
PROCEPT BioRobotics
Nov 14, 2024
Initiates: Hold
Price Target: $95
Current: $23.03
Upside: +312.51%
Glaukos
May 6, 2024
Upgrades: Buy
Price Target: $84 → $125
Current: $119.63
Upside: +4.49%
Profound Medical
Mar 21, 2023
Downgrades: Equal-Weight
Price Target: $5.5 → $10
Current: $6.69
Upside: +49.48%